The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib study combining the second-generation DNA hypomethylating agent (DHA) guadecitabine (SGI-110) and ipilimumab in patients with metastatic melanoma: the NIBIT-M4 Study.
 
Anna Maria Di Giacomo
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche/Genentech
 
Alessia Covre
Patents, Royalties, Other Intellectual Property - Own application
 
Pietro Taverna
Employment - Astex Pharmaceuticals
 
Sandra Coral
Patents, Royalties, Other Intellectual Property - Own application
 
Giovanni Amato
No Relationships to Disclose
 
Harold N. Keer
Employment - Astex Pharmaceuticals
 
James N. Lowder
Employment - Astex Pharmaceuticals
 
Diana Giannarelli
No Relationships to Disclose
 
Mohammad Azab
Employment - Astex Pharmaceuticals
 
Michele Maio
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Roche/Genentech
Research Funding - Astex Pharmaceuticals; Bristol-Myers Squibb; MedImmune
Patents, Royalties, Other Intellectual Property - Own applcation